HPV - Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity
Cancer - specific mortality for HPV - related oropharyngeal cancer higher among non - Hispanic Black and Hispanic men than White men (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, ENT, Pediatrics, Pharmacy, Journal, Source Type: news
Reduced-Dose RT Controls HPV+ Oropharynx Cancer (CME/CE)
(MedPage Today) -- Dramatic decline in toxicity (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 26, 2017 Category: Consumer Health News Source Type: news
David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer
In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer. (Source: CancerNetwork)
Source: CancerNetwork - September 15, 2017 Category: Cancer & Oncology Authors: David J. Sher, MD, MPH Tags: Head & Neck Cancer Oncology Journal Q Source Type: news
Hefty Price for HPV+ Oropharyngeal Cancer (CME/CE)
(MedPage Today) -- Healthcare costs approaching $140,000 for 2 years of care (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 25, 2017 Category: American Health Source Type: news
Average cost of first 2 years of oropharyngeal cancer treatment in Texas is $139,749
(American Association for Cancer Research) In Texas, the average cost for the first two years of health care after a diagnosis of oropharyngeal cancer was $139,749. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news
Newly developed nomograms provide accurate predictions for patients with oropharyngeal cancer
(NRG Oncology) NRG Oncology researchers recently developed and validated a nomogram that can predict 2-year and 5-year overall survival (OS) and progression-free survival (PFS) for patients with local-regionally advanced oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation-based therapy. This nomogram was developed with data from clinical trials NRG Oncology/RTOG 0129 and 0522. Results were published online in the Journal of Clinical Oncology on Aug. 4, 2017. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 21, 2017 Category: Cancer & Oncology Source Type: news
Oropharyngeal Cancer Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 1, 2017 Category: General Medicine Source Type: news
ASTRO bestows grants to survivor groups
The American Society for Radiation Oncology (ASTRO) has named two recipients...Read more on AuntMinnie.comRelated Reading:
ASTRO names Gold Medal winners
ASTRO publishes new guideline for SBRT in lung cancer
ASTRO releases oropharyngeal cancer guidelines
ASTRO partners with ASCO's CancerLinQ
ASTRO updates guidelines on painful bone metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2017 Category: Radiology Source Type: news
HPV Vaccination Prevents Cancers in Men, Too
For years, scientists have touted the HPV vaccination ’s power to reduce cervical cancer in women. Now, during Men’s Health Week, Texas physicians urge men to get vaccinated against HPV to prevent cancers. HPV causes several cancers in men and women, including oropharyngeal (cancers of the head and neck such as the throat and mouth), penile, anal, cervical and vaginal. Some cases are fatal. (Source: TMA News Room)
Source: TMA News Room - June 14, 2017 Category: Consumer Health News Source Type: news
ASTRO publishes new guideline for SBRT in lung cancer
The American Society for Radiation Oncology (ASTRO) has released a new clinical...Read more on AuntMinnie.comRelated Reading:
Societies release guideline for localized prostate cancer
ASTRO releases oropharyngeal cancer guidelines
ASTRO partners with ASCO's CancerLinQ
ASTRO updates guidelines on painful bone metastases
Elekta to support ASTRO safety initiative (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 13, 2017 Category: Radiology Source Type: news
Hitachi and MD Anderson to investigate IMPT versus IMRT for oropharyngeal cancer
Japanese-based Hitachi's subsidiary Hitachi Healthcare Americas has signed an agreement to collaborate with the University of Texas MD Anderson Cancer Centre to evaluate the intensity-modulated proton beam therapy (IMPT) in a clinical trial for oroph … (Source: Drug Development Technology)
Source: Drug Development Technology - June 8, 2017 Category: Pharmaceuticals Source Type: news
MD Anderson and Hitachi to collaborate in research for treatment of oropharyngeal cancer of the head and neck
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas Corporation, have today announced that they have entered into an agreement to collaborate on research for a unique randomized clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2017 Category: International Medicine & Public Health Source Type: news
Large Study Shows Reduced Oral HPV Infections With Vaccine Large Study Shows Reduced Oral HPV Infections With Vaccine
Rates of oral HPV infection were reduced in young adults who had been vaccinated, suggesting protection from oropharyngeal cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
